BENEFITS VERSUS RISKS OF PROTON PUMP INHIBITORS: ARE WE OPENING THE CAN OF WORMS
Journal Title: International Journal of Medical Research & Health Sciences (IJMRHS) - Year 2015, Vol 5, Issue 1
Abstract
Proton pump inhibitors (PPIs) are one of the most commonly used drugs worldwide They are indicated for treatment of Gastro-esophageal Reflux Disease (GERD), acid peptic disorders, stress ulcers and prophylaxis of NSAID induced ulcers.[1] PPIs are more efficacious than other drugs like histamine -2 receptor blockers for the treatment of these disorders.[1] Though PPIs are highly potent and effective acid suppressors they are often misused and prescribed irrationally. The incidence of irrational use of PPIs varies from 40-70 % in different studies. [2] In one of our previous studies 58 % of PPIs prescriptions were irrational. [2] These findings become much more significant in the light of recent findings which suggest correlation of long term use of PPIs to myocardial infarction and kidney injury. [3,4] The PPIs may be deemed safe for short term use but chronic use carries risk of hip fractures, infection with clostridium difficle, community acquired pneumonia.[2] PPIs exposure in elderly population was also found to be associated with hyperparathyroidism in one recently conducted study.[5] The ongoing long term studies for assessing the safety and association of PPIs with various serious outcomes may open up a new can of worms. Keeping in mind the benefits as well as risks of proton pump inhibitors, clinicians should judiciously use these drugs in practice. The patients should also be educated regarding the adverse outcomes of PPIs on long term therapy as these drugs are easily available without prescription.
Authors and Affiliations
Naser Ashraf Tadvi| Assistant Professor, Department of Pharmacology, College of Medicine, Majmaah University, Email id: nasertadvi@yahoo.co.uk, Sajid Hussain| Assistant Professor, Department of Pharmacology, College of Medicine, Majmaah University, Usama Bin Ghaffar| Assistant Professor, Department of Pathology, College of Medicine, Majmaah University
Keywords
Related Articles
- EP ID EP11571
- DOI 10.5958/2319-5886.2016.00018.7
- Views 281
- Downloads 10
INTRA-PAROTID NEUROFIBROMA OF FACIAL NERVE : A CASE REPORT
A 45-year-old male presented with a painless slowly growing mass in the region of the left parotid gland over a period of 4 years. The swelling was nontender, measuring 8cm*6cm and it was hard in consistency. Facial fu...
Studying Surgical Margin of skin melanoma of the face and its relapse after surgical treatment in patients referring to Razi Hospital and Cancer Institute of Imam Khomeini Hospital during 1992-2010
Melanoma is a malignant neoplasm caused by the uncontrolled growth of melanocytes and the production of skin pigmentation. Melanoma treatment varies depending on the type and location. To treat melanoma cutaneous (MC),...
Exploring the effectiveness of obstetrics and gynecology information systems in hospitals of a developing country: A qualitative content analysis
Obstetrics and gynecology information systems are designed to replace paper charts, interact with other clinical wards of hospital, and to better care for patients. This qualitative study was performed to explore the pe...
Evaluation of CO2 laser irradiation effect on enamel microhardness after incipient caries creation
Objective: The important mission in modern science of caries prevention is identification and providing the necessary actions for caries prevention to patients with an elevated risk of caries. The aim of this study was...
ADENOSINE DEAMINASE ACTIVITY AND INSULIN IN TYPE 2 DIABETES MELLITUS: DOES ADENOSINE DEAMINASE AFFECTS INSULIN LEVEL?
Aim: Correlation between Adenosine Deaminase activity and Insulin level in patients with Type 2 Diabetes Mellitus. Material & Method: We measured the serum level of Adenosine Deaminase (ADA), Insulin and Fasting Plasma...